Johannes Fruehauf is a founder and the president and executive director of LabCentral. A physician and biotech entrepreneur, prior to LabCentral he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Fruehauf earned his medical degree at the University of Frankfurt and his PhD at the University of Heidelberg (Germany).
The US biotech and life sciences industry has a long and proud history of driving medical innovations that have improved healthcare outcomes across a wide range of diseases and the overall... Read more »
Sponsored · Whitepaper
How to accelerate your life sciences business with every agreement
DocuSignFrom Our Partners · Special Report
Advice for funding and future transformational opportunities
Sponsored · Whitepaper
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption SystemsMerck/ArQule
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.